• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.

作者信息

Plusquellec Y, Houin G

机构信息

UFR de Mathématiques, Université Paul Sabatier, Toulouse, France.

出版信息

Med Eng Phys. 1995 Apr;17(3):172-6. doi: 10.1016/1350-4533(95)95706-g.

DOI:10.1016/1350-4533(95)95706-g
PMID:7795853
Abstract

A pharmacokinetic model is used to take into account multiple recirculations of drug occurring at various times after gall bladder emptying. If a dose D is initially administed, due to recirculation, an effective amount A* reaches the body. This value A* is expressed as a function of D and the model parameters, after oral administration or intravenous injection. Using areas under curves in two different situations, the reabsorption rate may be identified.

摘要

相似文献

1
Estimation of the effective amount entering the body for drugs subject to enterohepatic recirculations.
Med Eng Phys. 1995 Apr;17(3):172-6. doi: 10.1016/1350-4533(95)95706-g.
2
Drug recirculation model with multiple cycles occurring at unequal time intervals.具有在不等时间间隔发生多个循环的药物再循环模型。
J Biomed Eng. 1992 Nov;14(6):521-6. doi: 10.1016/0141-5425(92)90107-v.
3
Application of a pharmacokinetic model with multiple enterohepatic cycles to a new inotropic drug after infusion and oral administration.具有多个肠肝循环的药代动力学模型在一种新型强心药物静脉输注和口服给药后的应用。
J Pharm Sci. 1992 Oct;81(10):1020-3. doi: 10.1002/jps.2600811013.
4
A time-lag model for pharmacokinetics of drugs subject to enterohepatic circulation.一种用于受肝肠循环影响药物的药代动力学时滞模型。
J Pharm Sci. 1982 Mar;71(3):297-302. doi: 10.1002/jps.2600710308.
5
Estimation of area under the curve for drugs subject to enterohepatic cycling.对经历肠肝循环的药物的曲线下面积的估算。
J Pharmacokinet Biopharm. 1985 Dec;13(6):589-608. doi: 10.1007/BF01058903.
6
Prediction of the possibility of the second peak of drug plasma concentration time curve after iv bolus administration from the standpoint of the traditional multi-compartmental linear pharmacokinetics.从传统多房室线性药代动力学角度预测静脉推注给药后药物血浆浓度时间曲线第二个峰值出现的可能性。
J Pharm Sci. 2008 Jun;97(6):2385-93. doi: 10.1002/jps.21151.
7
Enterohepatic circulation: physiological, pharmacokinetic and clinical implications.肠肝循环:生理、药代动力学及临床意义。
Clin Pharmacokinet. 2002;41(10):751-90. doi: 10.2165/00003088-200241100-00005.
8
A new method to estimate parameters of pharmacokinetics with enterohepatic circulation.
Eur J Drug Metab Pharmacokinet. 1993 Apr-Jun;18(2):131-9. doi: 10.1007/BF03188787.
9
Pharmacokinetics and metabolism of lonidamine in rats: evidence of enterohepatic recycling.氯尼达明在大鼠体内的药代动力学和代谢:肠肝循环的证据。
Drug Metab Rev. 1997 Feb-May;29(1-2):219-34. doi: 10.3109/03602539709037583.
10
Pharmacokinetics of drugs subject to enterohepatic circulation.具有肠肝循环的药物的药代动力学。
J Pharm Sci. 1979 Jun;68(6):792-4. doi: 10.1002/jps.2600680634.